Renks, Orders

Renk's €582M Q1 Orders and Dividend Hike Overshadowed by FCAS Fallout and Technical Weakness

13.06.2026 - 07:05:08 | boerse-global.de

Renk shares close at €47.20, down 19% below 200-day MA, after Germany cancels FCAS project. Despite strong Q1 orders, technicals show RSI near oversold; support at €42.12. Q2 results due Aug 6.

Renk Stock at 52-Week Low: FCAS Collapse, Dividend Drag, Technical Weakness
Renks - Renk's €582M Q1 Orders and Dividend Hike Overshadowed by FCAS Fallout and Technical Weakness 13.06.2026 - Bild: über boerse-global.de

Renk’s shares ended a turbulent week under a triple cloud: the collapse of the Franco-German Future Combat Air System (FCAS), a dividend-adjusted decline, and a persistent loss of investor confidence that has left the stock trading near its 52-week low. The Augsburg-based drivetrain specialist closed Friday at €47.20, down 3.4% on the day and almost 19% below its 200-day moving average of €58.34. A second quote put the price at €47.33, underscoring the intraday volatility.

German Defence Minister Boris Pistorius has officially pulled the plug on the long-troubled FCAS project, citing irreconcilable differences between Airbus and Dassault. Within days, a new consortium of eight German industrial heavyweights announced plans to develop a sixth-generation combat aircraft, unveiled at the ILA Berlin Air Show. For Renk, a key supplier to such platforms, the sudden strategic reordering injects immediate uncertainty. The news was compounded by BlackRock trimming its voting rights stake from 4.44% to 4.28%, a further signal of institutional caution.

Operationally, however, the company delivered a robust first quarter. Order intake surged to €582.3 million, the highest ever for an opening quarter, pushing the total order backlog to €6.9 billion. Revenue climbed to roughly €284 million, while earnings per share jumped to €0.15 from virtually nothing a year earlier. Management has laid out ambitious targets for 2030: revenue of €2.8–3.2 billion and an EBIT margin above 20%. The dividend was lifted 38% to €0.58 a share, a vote of confidence backed by the full order book—but the market chose to focus on the ex-dividend adjustment and the FCAS fallout.

Should investors sell immediately? Or is it worth buying Renk?

The technical picture offers little comfort. The relative strength index has fallen to 39.9, edging toward oversold territory, yet no reversal signal has materialised. The stock remains 14% in the red year to date and a staggering 47% below its 52-week high of €88.73. The only firm support stands at the 52-week trough of €42.12, plumbed on 13 May 2026. Should that level give way, a clear floor will be missing. On the upside, a sustained recovery would require a decisive break above the 50-day line at €51.51—a climb of roughly 9% from current levels, and one that annualised volatility of more than 51% suggests will be anything but smooth.

All eyes now turn to 6 August, when Renk reports second-quarter results. In the meantime, the new fighter-jet consortium could provide a catalyst if concrete contract awards emerge from Berlin. For a stock that has been hammered by both geopolitics and chart damage, any sign of tangible progress may be the spark needed to finally reverse the slide.

Ad

Renk Stock: New Analysis - 13 June

Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Renk analysis...

en | DE000RENK730 | RENKS | boerse | 69531763 |